nuclivision

Nuclivision is a Belgian healthtech startup based in Ghent, founded in 2022. The company focuses on developing software solutions for nuclear medicine, particularly in positron emission tomography (PET) imaging. Its mission is to improve the efficiency, safety, and accessibility of PET scans, which are vital for diagnosing conditions like cancer and Alzheimer's disease. The flagship product, Nuclarity, is an AI-powered platform that enhances PET imaging workflows. It utilizes advanced image enhancement algorithms to allow for lower-dose PET scans without sacrificing image quality or diagnostic accuracy. This innovation reduces scan times and radiation exposure, increasing patient safety and making PET scans more accessible. Nuclarity integrates smoothly into existing clinical workflows, supporting the entire imaging process from acquisition to interpretation. Nuclivision's technology addresses key challenges in nuclear medicine, including the growing demand for PET imaging, the need to reduce radiation exposure, and the high costs associated with nuclear medicine scans. The company has received endorsements from medical professionals and secured significant investment to support its growth and expansion plans.

• Employees 16
• Founded 2022